PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
04-Feb-2025 Enduro Genetics raises €12 million to unlock the future of scalable bioproduction Enduro Genetics
04-Feb-2025 Dxcover accelerates growth with new funding round and strengthens the leadership team Dxcover
04-Feb-2025 CLS Clock Laser System: Elevating Qubit Fidelity TOPTICA Photonics AG
04-Feb-2025 Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology Alys Pharmaceuticals
04-Feb-2025 EAACI-ESCD Skin Allergy Meeting (SAM) 2025: Pioneering Innovations in Skin Allergy and Contact Dermatitis EAACI-ESCD
04-Feb-2025 Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024 Medacta Group SA
03-Feb-2025 CHMP recommends subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer Janssen-Cilag International NV
03-Feb-2025 Eckert & Ziegler SE: IT Incident Affects Eckert & Ziegler SE's Communication Channels Eckert & Ziegler SE
03-Feb-2025 CHMP recommends subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer Janssen-Cilag International NV
03-Feb-2025 Aplagon Announces EUR 7 Million Financing to Advance its APAC Therapeutic for Thrombo-Inflammatory Diseases into Phase 2A Clinical Trials Aplagon
03-Feb-2025 Terclara (MOB-015) is now being launched in Norway Moberg Pharma AB
03-Feb-2025 Sanofi announces buy back of shares from L’Oréal Sanofi
31-Jan-2025 Marinomed Biotech AG: Changes to the Management Board Marinomed Biotech AG
31-Jan-2025 RYSTIGGO®▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two new administration methods UCB
31-Jan-2025 European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents ViiV Healthcare
31-Jan-2025 BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care BrightHeart
31-Jan-2025 Sarclisa is the first anti-CD38 treatment in combination with standard-of-care VRd approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant. Sanofi
31-Jan-2025 TOPTICA Unveils Ultra-Low Noise 532 nm Laser TOPTICA
31-Jan-2025 Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England Vertex
31-Jan-2025 European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents GSK plc